BefejeződöttFázis nélkül
Repetitive Transcranial Magnetic Stimulation for Dementia
A legfontosabb adatok
- Ki végzi
- VA Office of Research and Development
- Hol
- Palo Alto (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 32 fő vett részt
- Kezdés
- 2016. jan. 1.
- Befejezés
- 2025. szept. 16.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- RTMS
- sham
- A regiszteradat frissítve
- 2025. szeptember 30.
Ki vehet részt
- Életkor
- 55 év – 99 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 18 feltétel megnézéseKevesebb
Ki vehet részt
- Veterans aged 55 years or older
- Diagnosed with Mild Cognitive Impairment (MCI) or dementia likely due to Alzheimer's disease
- Ability to obtain a Motor Threshold, determined during the screening process
- With an adequately stable condition and living environment to enable attendance at scheduled clinic visits
- If on a prescription medication for cognition that medication dose will be stable for at least 4 weeks prior to randomization into the study and participant will be willing to remain on a stable regimen during the acute treatment phase
- Able to read, verbalize understanding, and voluntarily sign the Informed Consent Form to be signed by the participant, or a designated legal representative when the participant lacks decision making capacity prior to participating in any study- specific procedures or assessments
Ki nem vehet részt
- Patients with prior exposure to rTMS or electroconvulsive therapy (ECT)
- Unable to safely withdraw, at least two weeks prior to treatment commencement, from medications that substantially increase the risk of having seizures
- Current or Prior history of a seizure disorder as determined by patient report or chart review
- Participation in another concurrent interventional clinical trial
- Current or prior history of a mass lesion, cerebral infarct or other non-cognitive, active central nervous system (CNS) disease that would increase the risk for seizure
- Have a cardiac pacemaker or a cochlear implant
- Not fluent in English or a hearing impairment severe enough to impair comprehension
- Have an implanted device deep brain stimulation or metal in the brain
- Current substance abuse not including caffeine or nicotine as determined by patient report or chart review
- Active current suicidal intent or plan as determined by patient report or chart review
- Traumatic brain injury within the last two months
- Known current psychosis as determined by patient report or chart review
Helyszínek itt: Egyesült Államok
- VA Palo Alto Health Care System, Palo Alto, CAPalo Alto, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose is to is to study if repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in patients with neurodegenerative conditions which may manifest as mild to moderate cognitive impairment and, in late phase, dementia. This study also intends to investigate if the responses to rTMS intervention are either positively or negatively correlated with the initial severity of cognitive impairment.
A vizsgálat 2 csoportja
- RTMSA vizsgált kezelés
repetitive transcranial magnetic stimulation
- shamSzínlelt kezelés, összehasonlításként
sham noise to block the sound of treatment
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Publikációk
- Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities.Journal of Alzheimer's disease : JAD, 2022
- A regiszteradat frissítve
- 2025. szeptember 30.